Table 4.
Summary of Changes in HF Epidemiology between 1990–2009
| 2000–2009 (vs. 1990–1999) | |
|---|---|
|
| |
| Incidence | |
| All HF | ← → |
| HFREF | ↓ |
| HFPEF | ↑ |
|
| |
| CVD and non-CVD Mortality* | |
| All HF | ← → |
| HFREF | ← → |
| HFPEF | ← → |
|
| |
| Prevalent use of cardiovascular meds in HF | |
| Aspirin | ↑ |
| Beta blockers | ↑ |
| Angiotensin-converting enzyme inhibitors | ← → |
| Lipid-lowering medications | ↑ |
| Diuretics | ↓ |
| Digoxin | ↓ |
There was no change between decades in mortality for overall mortality, CVD mortality, or non-CVD mortality.